Emerging Infections: What Have We Learned After 15 Years?  by Heymann, D.
e iona
w
p
d
E
1
5
E
1
D
I
e
c
a
l
h
g
a
e
a
e
e
r
u
e
p
w
a
A
o
T
a
v
T
i
i
o
t
t
i
o
T
u
t
d
T
(
5
H
D
T
B
i
a
m
w
i
t
i
r
b
m
t
A
v
n
c
v
o
o
A
s
d
r
t
a
s
T
s
a
v
c
d
536 13th Internat
ill describe two case studies of successful HIV/AIDS hospice
rograms in Southeast Asia.
oi:10.1016/j.ijid.2008.05.137
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nfectious diseases are complex, dynamic, and constantly
volving. Examples during the past 15 years range from
hanges in transmission patterns of human monkeypox
nd dengue; more frequent re-emergence of cholera,
egionnaire’s disease, E. coli 0157, hepatitis C and, the
aemorrhagic fevers - Marburg, Lassa and Ebola; and emer-
ence of bovine spongiform encephalopathy (BSE), severe
cute respiratory syndrome (SARS) and H5N1 inﬂuenza.
Causes of emergence and re-emergence include weak-
ned public health infrastructure, increases in human
nd domestic animal populations, rapid urbanization, and
ffects on the environment from global warming to defor-
station and ﬂooding. Human behavior also plays a major
ole, ranging from unsafe sexual practices to over- or
nder-prescribing of antimicrobial drugs, patient adher-
nce, unregulated sale, and indiscriminate use in humans,
lants and animals.
Emerging and re-emerging infections occur in a world
here international travel and trade facilitate their spread,
nd where their impact affects economies as well as health.
ttempts at regulation to prevent their international spread
ccurred ﬁrst in the 14th century quarantines in Venice.
hey continued during the 19th and 20th centuries in Europe
nd the Americas through a series of conferences and con-
entions leading to the International Health Regulations.
he goal of the Regulations is to strengthen national capac-
ties to detect and respond to emerging or re-emerging
nfections when and where they occur, with the guarantee
f a safety net of collective detection and response should
hey cross international borders.
The lesson over the past 15 years - whether from
he global response to SARS or preparations for the next
nﬂuenza pandemic - is that collective action will decrease
ur vulnerability, and increase our public health security.
he challenge is to ensure resources for our collective action
nder the framework of the International Health Regula-
ions.
oi:10.1016/j.ijid.2008.05.138
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ackground: Several studies have shown that watchful wait-
ng management of acute otitis media (AOM) can be an
lternative to immediate antibiotics. In practice, clinicians
ay be more comfortable using the watchful waiting option
hen the child has mild symptoms and the ear is not severely
nﬂamed. Regarding clinical trials, standardized criteria for
he diagnosis of AOM, and a clear description of TM ﬁnd-
ngs has often been lacking, making interpretation of study
esults somewhat difﬁcult. The objective of this paper will
e to deﬁne AOM, review the development of an Ear Card
ethodology for assessing the child with AOM, and describe
he effective use of the Ear Card in a clinical trial.
Methods: The Ear Card system for assessing the child with
OM was evaluated for concurrent correlation, sequence
alidity and reliability against previously published question-
aires. Responsiveness was assessed during a randomized
linical trial.
Results: The system demonstrated excellent sequence
alidity, concurrent correlation and reliability.
Conclusions: The Ear Card combines a parent assessment
f severity using a faces scale and the clinician’s assessment
f the tympanic membrane to provide an evaluation of total
OM severity that can be used to characterize AOM signs and
ymptoms at enrollment and to evaluate a patients progress
uring treatment. For research, clinical investigators can be
eliably trained using the Ear Card, so that clinical charac-
eristics at enrollment and follow-up can be clearly deﬁned
nd scored. The method is sufﬁciently sensitive to detect
mall differences in outcomes between treatment groups.
he Ear Card has also been useful in teaching residents and
tudents to accurately assess the tympanic membrane.
Clinicians, AOM researchers, and clinical educators from
round the world have requested our copyrighted electronic
ersion of the Ear Card, which may be freely used for patient
are, teaching and research.
oi:10.1016/j.ijid.2008.05.139
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n the last decade multiple clinical antimicrobials with new
ntibiotics have been performed in children. During this
ime, the design of the clinical trial improved dramati-
ally to take into consideration multiple factors but always
eeping as the most critical factor the resolution of signs
nd symptoms from the participant children. In this regard,
rial have taking into consideration the use of innovative
